Total amount: € 0,00
Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014
Online ISSN 1827-1820
WHAT’S NEW IN 2009
Walling H. W.
Town Square Dermatology, Coralville, IA, USA
Lentigo maligna (LM) is a cutaneous malignancy with increasing incidence and significant risk of morbidity. Early diagnosis of LM requires a high index of suspicion for the often subtle atypical signs of pigmented lesions on sun-damaged skin. A variety of treatment options are available to the physician. Surgical options include simple excision and margin-control techniques such as staged excision and Mohs micrographic surgery. Tissue may be embedded vertically or en face, and processed as frozen or paraffin-embedded sections. Destructive options include radiotherapy, cryotherapy, curettage, and electro-destruction. Topical therapy may be appropriate in selected cases; immunotherapy with topical imiquimod may have advantages over other topical agents. The opportunity for curative therapy is maximized by surgical treatment. Margin-control surgery offers the highest cure rate while minimizing loss of normal tissue.